Related Experiment Video

Updated: Dec 9, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

5.3K

Pediatric Care in the Age of COVID-19

Catherine Rodriguez, Calli Morris, Albert L Hsu

    Pediatric Annals
    |September 15, 2020
    PubMed

    Insights

    The coronavirus 2019 pandemic negatively impacted children's health, causing decreased vaccination rates and widening educational disparities. Future healthcare encounters may be affected by these significant collateral effects.

    Area of Science:

    • Pediatrics
    • Public Health
    • Sociology

    Background:

    • The coronavirus 2019 (COVID-19) pandemic has presented unprecedented challenges to healthcare systems globally.
    • Children's health and well-being are particularly vulnerable to the disruptions caused by the pandemic.

    Purpose of the Study:

    • To explore the perspectives of pediatricians on the patient experience during the COVID-19 pandemic.
    • To identify the collateral effects of the pandemic on children's health and social implications.
    • To anticipate future healthcare encounters and their potential challenges.

    Main Methods:

    • Qualitative perspectives shared by two pediatricians.
    • Analysis of patient experience, healthcare delivery, and social impacts.
    • Review of collateral effects on children, including hospital access and vaccination rates.

    Main Results:

    • Significant collateral effects on children include restricted hospital visitation, closure of child-friendly facilities, and a concerning decline in vaccination rates.
    • Educational disparities are expected to widen, particularly for children lacking home technology access.
    • The pandemic has reshaped pediatric patient experiences and healthcare delivery.

    Conclusions:

    • The COVID-19 pandemic has profound and far-reaching consequences for pediatric health and development.
    • Addressing decreased vaccination rates and educational disparities is crucial for mitigating long-term impacts on children.
    • Pediatric healthcare must adapt to the evolving landscape shaped by the pandemic.

    More Related Videos

    An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient07:16

    An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

    Published on: November 30, 2022

    4.2K
    A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn11:27

    A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

    Published on: April 7, 2023

    7.1K

    Related Concept Videos

    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    131
    Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

    Transmission-based Precautions I: Contact, Enteric, and Droplets

    Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
    Contact Precautions:
    Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
    4.3K
    Transmission-based Precautions II: Airborne and Protective Environment01:25

    Transmission-based Precautions II: Airborne and Protective Environment

    Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
    Airborne precautions:
    Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
    1.7K
    Standard Precaution01:26

    Standard Precaution

    Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
    Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
    2.6K
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    135
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    145